TickerFactsScreenerDevelopers

Vistagen Therapeutics, Inc. (VTGN) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

1999: -$225.5K2000: -$844.1K2001: -$2.51M2002: -$4.58M2003: -$4.95M2004: -$13.69M2005: -$14.74M2006: -$16.50M2007: -$17.45M2008: -$22.17M2009: -$26.68M2010: -$26.34M2011: -$32.88M2012: -$5.71M2013: -$12.56M2014: -$12.80M2015: -$20.54M2016: -$2.98M2017: $615.8K2018: $6.92M2019: $7.08M2020: -$5.73M2021: $91.98M2022: $64.72M2023: $12.08M2024: $114.29M2025: $70.39M2026: $35.52M$35.52M
1999Shareholders' Equity (USD)2026
Fiscal YearShareholders' EquityChange YoY
2026$35.52M-49.5%
2025$70.39M-38.4%
2024$114.29M+846.1%
2023$12.08M-81.3%
2022$64.72M-29.6%
2021$91.98M+1705.4%
2020-$5.73M-181.0%
2019$7.08M+2.3%
2018$6.92M+1023.2%
2017$615.8K+120.7%
2016-$2.98M+85.5%
2015-$20.54M-60.5%
2014-$12.80M-1.9%
2013-$12.56M-120.1%
2012-$5.71M+82.6%
2011-$32.88M-24.9%
2010-$26.34M+1.3%
2009-$26.68M-20.4%
2008-$22.17M-27.0%
2007-$17.45M-5.7%
2006-$16.50M-12.0%
2005-$14.74M-7.7%
2004-$13.69M-176.7%
2003-$4.95M-7.9%
2002-$4.58M-82.5%
2001-$2.51M-197.5%
2000-$844.1K-274.3%
1999-$225.5K—